CTRI/2020/03/023760尚未招募未知
To evaluate the efficacy and safety of continuous quadratus lumborum block for postoperative analgesia after laparoscopic nephrectomy â?? A Randomised controlled clinical trial
All India Institute of Medical Sciences Jodhpur0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •After approval from institutional ethical committee and written informed consent, patients belonging to American Society of Anaesthesiologists (ASA) physical status grade I and II, 18-65 years of age scheduled for laparoscopic nephrectomy will be included in the study.
排除标准
- •Patients with infection at the block site, coagulation disorders, morbid obesity (BMI >40 kg/m2), allergy to local anaesthetic agent, major cardiac-respiratory disorders, severe renal or hepatic dysfunction, pre-existing neurological deï¬?cit, psychiatric illness and excessive bleeding during the procedure will be excluded from the study.
研究者
相似试验
已完成
不适用
Evaluation of the safety and efficacy of continuous use of skincare formulationsHealthyJPRN-UMIN000039938Beauty & Health Research Inc.45
已完成
不适用
Evaluation of the safety and efficacy of continuous use of skincare formulationsHealthyJPRN-UMIN000039937Beauty & Health Research Inc.46
招募中
不适用
Intravenous Labetalol for intracerebral hemorrhageBlood pressure control and hematoma volume control in patients with spontaneous intracerebral hemorrhageLabetalolblood pressurehemorrhagic strokeintracranial hemorrhageTCTR20240423003Faculty of Medicine, Thammasat University100
尚未招募
3 期
A clinical trial to study the effects of two drugs, sustained release and immediate release mucoregulator in patients with bronchial asthma.CTRI/2010/091/000571Sun Pharmaceutical Industries Ltd.200
招募中
2 期
Assessment of efficacy and safety of continouation maintenance therapy with gemcitabine after cisplatin-gemcitabine induction chemotherapy in advanced squamous cell lung cancer (KTORG1302)squamous cell lung cancerJPRN-UMIN000010721Kyoto Thoracic Oncology Research Group (KTORG)60